Weiqin Jiang
Weiqin Jiang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
James J. Fiordeliso
Johnson & Johnson Pharmaceutical Research and Development L.L.C. , Drug Discovery , Raritan, New Jersey, USA
5 shared publicationsZhihua Sui
Johnson & Johnson Pharmaceutical Research and Development L.L.C. , Drug Discovery , Raritan, New Jersey, USA
5 shared publicationsJoseph Gunnet
Johnson & Johnson Pharmaceutical Research & Development L.L.C., Drug Discovery, 1000 Route 202, Raritan, NJ 08869, USA
3 shared publicationsJun Xu
Johnson & Johnson Pharmaceutical Research & Development L.L.C., Drug Discovery, 1000 Route 202, Raritan, NJ 08869, USA
3 shared publicationsKeith Demarest
Johnson & Johnson Pharmaceutical Research & Development L.L.C., Drug Discovery, 1000 Route 202, Raritan, NJ 08869, USA
3 shared publicationsOlivia Linton
Johnson & Johnson Pharmaceutical Research & Development L.L.C., Drug Discovery, 1000 Route 202, Raritan, NJ 08869, USA
3 shared publications
Latest Publications
- 1 April 2007
- Published by Taylor & Francis in Synthetic Communications
- Vol. 37 (8) , 1237-1249
Facile Synthesis of 3,3‐Dialkyl‐6‐phenyl‐imidazopyridinones
A series of novel 3,3‐dialkylated imidazopyridinones bearing 6‐aryl groups were designed as mimetics of active progesterone antagonists, 3,3‐disubstituted‐5‐arylindoles. The four‐step synthetic route is described. The key steps are base‐catalyzed cyclization, base‐catalyzed alkylation, and Suzuki coupling reaction.
- 1 April 2007
- Published by Taylor & Francis in Synthetic Communications
- Vol. 37 (8) , 1237-1249
Facile Synthesis of 3,3‐Dialkyl‐6‐phenyl‐imidazopyridinones
A series of novel 3,3‐dialkylated imidazopyridinones bearing 6‐aryl groups were designed as mimetics of active progesterone antagonists, 3,3‐disubstituted‐5‐arylindoles. The four‐step synthetic route is described. The key steps are base‐catalyzed cyclization, base‐catalyzed alkylation, and Suzuki coupling reaction.
- 1 March 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1471-1474
Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist
- 1 March 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1471-1474
Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist
- 1 October 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (19) , 6726-6732
New progesterone receptor antagonists: Phosphorus-containing 11β-aryl-substituted steroids
- 1 October 2006
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 14 (19) , 6726-6732
New progesterone receptor antagonists: Phosphorus-containing 11β-aryl-substituted steroids
- 28 December 2002
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (3) , 441-444
Furoyl and Benzofuroyl Pyrroloquinolones as Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Synthesis of furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors was reported. Their in vitro potencies in inhibiting PDE5 and selectivity in inhibiting other PDE isozymes (PDE1−4 and PDE6) were evaluated. Some of these compounds are more potent than sildenafil with better selectivity toward PDE1 and PDE6. Incorporation of solublizing groups resulted in bioavailable analogues. Selected compounds showed in vivo efficacy in anesthetized dog model for penile erection.
- 28 December 2002
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (3) , 441-444
Furoyl and Benzofuroyl Pyrroloquinolones as Potent and Selective PDE5 Inhibitors for Treatment of Erectile Dysfunction
Synthesis of furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors was reported. Their in vitro potencies in inhibiting PDE5 and selectivity in inhibiting other PDE isozymes (PDE1−4 and PDE6) were evaluated. Some of these compounds are more potent than sildenafil with better selectivity toward PDE1 and PDE6. Incorporation of solublizing groups resulted in bioavailable analogues. Selected compounds showed in vivo efficacy in anesthetized dog model for penile erection.
- 12 December 2002
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 5 (1) , 43-46
Potassium Superoxide as an Alternative Reagent for Winterfeldt Oxidation of β-Carbolines
Potassium superoxide was examined as an alternative oxidation reagent for the Winterfeldt reaction. KO2 was found to be superior to the original Winterfeldt protocol for base-sensitive substrates.
- 12 December 2002
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 5 (1) , 43-46
Potassium Superoxide as an Alternative Reagent for Winterfeldt Oxidation of β-Carbolines
Potassium superoxide was examined as an alternative oxidation reagent for the Winterfeldt reaction. KO2 was found to be superior to the original Winterfeldt protocol for base-sensitive substrates.